Home » FDA Hikes Generic Drug Application Fees for FY 2019
FDA Hikes Generic Drug Application Fees for FY 2019
Drugs Regulatory Affairs
The FDA released its GDUFA II user fees for fiscal 2019 — including a significant hike for generic drug applicants.
The new GDUFA II fees, which take effect Oct. 1, raise large-size operation generic drug applicant program user fees from $1,590,792 to $1,862,167. For medium scale operations, the fee is increasing from $636,317 to $744,867, and for small operations the fee jumps from $159,079 to $186,217.
The agency is also upping fees for ANDA applications and drug master files. For ANDAs, the fee is set to rise from $171,823 to $178,799 and the fee for drug master files will go up from $47,829 to $55,013. All applicants that submit an ANDA must pay the FY 2019 filing fee on or after Oct. 1.